Previous 10 | Next 10 |
When it comes to relatively stable healthcare growth stocks, DexCom (NASDAQ: DXCM) and Abbott Laboratories (NYSE: ABT) just might fit the bill. Worth around $61 billion, the continuous glucose monitor (CGM) specialist DexCom is small compared to medical device giant Abbott's...
A bullish flag pattern has emerged in the chart of Dexcom Inc. (DXCM), where the stock is just under a resistance line. If DXCM breaks through this level, a breakout could occur. Read more if you would like to learn how to profit from this trade. Dexcom Inc. ( DXCM ) designs and commercia...
My new portfolio has already seen most companies release earnings, and results look promising. Therefore, I will cover the first thirteen companies in this article, and then the last twelve after all reports have been filed. I will be quite brief with my summaries, but I will cove...
Shares of DexCom Inc. (NASDAQ:DXCM) traded today at $649.00, eclipsing its 52-week high. Approximately 103,000 shares have changed hands today, as compared to an average 30-day volume of 524,000 shares. In the past 52 weeks, shares of DexCom Inc. have traded between a low of $305.63 and ...
Do You Have These Top Health Care Stocks On Your Watchlist Right Now? As investors look for the top stocks to buy in the stock market today, the relevance of an industry to our daily lives plays an important factor. Health care stocks will likely be as relevant as it is today a ...
During National Diabetes Awareness Month and World Diabetes Day, people with diabetes and their support systems around the globe band together to help the diabetes community feel more seen and heard Global activities, including a virtual Congressional testimony from Patti La...
The following slide deck was published by DexCom, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: DexCom, Inc. 2021 Q3 - Results - Earnings Call Presentation
Recording the second biggest intraday gain for the year, DexCom (DXCM +8.5%) shares have reached a new 52-week high after the company trounced the Street forecasts with its Q3 2021 earnings. Its guidance raise also exceeded analyst expectations. “At current valuation, that was all...
DexCom, Inc. (DXCM) Q3 2021 Results Conference Call October 29, 2021 4:30 PM ET Company Participants Kevin Sayer – Chairman, President and CEO Jereme Sylvain – Chief Financial Officer Jake Leach – Chief Technology Officer Sean Christensen – Head of Investor Relatio...
Image source: The Motley Fool. DexCom Inc (NASDAQ: DXCM) Q3 2021 Earnings Call Oct 28, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: DexCom Inc (DXCM) Q3 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...